Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver (Q42540890)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1998

Language	Label	Description	Also known as
English	Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver	scientific article published on January 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

author name string

Inoue I

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Noji S

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Awata T

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Takahashi K

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Nakajima T

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sonoda M

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Komoda T

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Katayama S

8

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

135-144

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

The Peroxisome Proliferator-Activated Receptor α (PPARα) Regulates the Plasma Thiobarbituric Acid-Reactive Substance (TBARS) Level

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

A simple fluorometric assay for lipoperoxide in blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Cloning and sequencing of a rat CuZn superoxide dismutase cDNA. Correlation between CuZn superoxide dismutase mRNA level and enzyme activity in rat and mouse tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Differential patterns of antioxidant enzyme mRNA expression in guinea pig lung and liver during development

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Lipid peroxide levels of serum lipoprotein fractions of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900249-5

7 January 2021

Identifiers

10.1016/S0024-3205(98)00249-5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42540890&oldid=1961245413"